Robert F. Kennedy Jr’s confirmation hearings began Wednesday before the Senate Finance Committee. He appears before the ...

President Donald Trump’s budget office has rescinded an order freezing spending on federal grants, less than two days after ...

President Donald Trump said he is directing the opening of a detention center at Guantanamo Bay to hold up to 30,000 migrants who are living illegally in the United States.

Scientists don’t know exactly how the mind-robbing disease forms. There’s disagreement ... slowing of the worsening of Alzheimer’s — Leqembi and Kisunla — work by targeting that sticky ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.

LEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with mild cognitive impairment (MCI) or mild dementia stage of disease (collectively referred to as early AD ...

Order Your Report Now For A Swift Delivery: What are the Major Drivers of the Leqembi Market? The increasing prevalence of Alzheimer's disease is a compelling factor contributing to the growth ...

INDICATION Monoclonal antibodies directed against aggregated forms of beta amyloid, including LEQEMBI, can cause ARIA, characterized as ARIA with edema (ARIA-E) and ARIA with hemosiderin ...

The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the monthly intravenous (IV) maintenance regimen of Leqembi ® (lecanemab-irmb ...